AZ entered the AL amyloidosis arena via its $39 billion takeover ... Neurotech's cell therapy gets FDA nod for eye disorder MacTe... Neurotech Pharma's cell therapy Encelto has become the first ...
Researchers from Osaka University find that peristaltic pump action and high shear flow forces promote amyloid nucleation. The factor that tips you over the edge from being at risk for a disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback